-
-
-
-
-
-
-
Dianthus Therapeutics (DNTH) Reiterated at Buy by Stifel
-
-
-
-
-
-
-
Raymond James Upgrades Dianthus Therapeutics (DNTH) to Strong Buy
-
-
-
-
-
-
-
William Blair Reiterates Outperform Rating on Dianthus Therapeutics (DNTH): "remain bullish here"
-
-
-
-
-
-
-
This biotech stock is a Top Pick for 2026 at Oppenheimer
-
-
-
-
-
-
-
Dianthus Therapeutics (DNTH) PT Raised to $60 at Oppenheimer
-
-
-
-
-
-
-
Dianthus Therapeutics (DNTH) PT Raised to $63 at Raymond James
-
-
-
-
-
-
-
William Blair Starts Dianthus Therapeutics (DNTH) at Outperform
-
415,794 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

